Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 03 1995, 149-155, Vol 2, No. 2
HK Johansen, A Norgaard, LP Andersen, P Jensen, H Nielsen and N Hoiby
Cystic fibrosis (CF) patients suffer from many of the gastrointestinal
conditions which occur in non-CF individuals, e.g., dyspepsia and peptic
ulceration. These symptoms may be caused by Helicobacter pylori but could
also be due to either pancreatic insufficiency or the intensive antibiotic
treatment used in CF patients. Since CF patients chronically infected with
Pseudomonas aeruginosa produce antibodies against a wide range of antigens,
including antigens common to many other bacteria, e.g., GroEL and
lipopolysaccharide, we studied, by the Western blot (immunoblot) technique,
the specificity of immunoglobulin G antibodies to H. pylori in Danish CF
patients chronically infected with P. aeruginosa, CF patients without P.
aeruginosa infection but with Haemophilus influenzae infection, patients
with dyspeptic ulcers associated with H. pylori, and patients recovering
from acute Campylobacter jejuni or Campylobacter coli infection. Sera from
CF patients with chronic P. aeruginosa or H. influenzae infection and
patients recovering from acute C. jejuni infection cross-reacted with H.
pylori antigens. A strong cross-reacting protein antigen at approximately
14 kDa and minor cross-reactive antigens at approximately 27, 30, and 60
kDa (the heat shock protein GroEL is equivalent to the common antigen of P.
aeruginosa) could be demonstrated. The results of this study show that high
immunoglobulin G antibody titers against H. pylori in CF patients cannot be
regarded as indicating present or past H. pylori infection unless their
specificity is proven by absorption studies.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori
Department of Clinical Microbiology, Danish Cystic Fibrosis Centre, Rigshospitalet, Copenhagen.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |